• Refine Query
  • Source
  • Publication year
  • to
  • Language
  • 5
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • Tagged with
  • 7
  • 7
  • 7
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • About
  • The Global ETD Search service is a free service for researchers to find electronic theses and dissertations. This service is provided by the Networked Digital Library of Theses and Dissertations.
    Our metadata is collected from universities around the world. If you manage a university/consortium/country archive and want to be added, details can be found on the NDLTD website.
1

An investigation into the antioxidative potential and regulatory aspects of liver tryptophan 2,3-dioxygenase by tryptophan and related analogues

Antunes, Ana Paula Martins January 1998 (has links)
The amino acid, tryptophan, obtained through dietary means, is metabolised by the enzymes tryptophan 2,3-dioxygenase (TDO), indoleamine 2,3-dioxygenase (IDO) and tryptophan hydroxylase. All the enzymes have an effect on circulating tryptophan levels, especially TDO, since it is the major site of tryptophan catabolism in the liver and results in the production of kynurenine metabolites, viz. kynurenine, kynurenic acid, 3-hydroxyanthranilic acid and quinolinic acid. Extrahepatically, IDO is responsible for the synthesis of the kynurenine metabolites. Tryptophan 2,3-dioxygenase and IDO activity is increased by hormones or substrates such as tryptophan, and inflammation, in the case of IDO. Tryptophan availability for serotonin (5-HT) synthesis by the enzyme tryptophan hydroxylase is primarily dependent on TDO activity. A study was attempted in order to ascertain whether any of the endogenous metabolites of the kynurenine and serotonergic pathways would be able to inhibit TDO activity. Results showed that although the kynurenines had no effect, the indoleamines, except for the indoleacetic acids, were able to reduce TDO activity. 6-Methoxy-2-benzoxazolinone (6-MBOA), a structural analogue to melatonin, was the most potent inhibitor with a reduction in activity of 55 % compared with the control. The pineal gland in the rat brain has been shown to have the highest IDO activity. With induction, the kynurenine metabolite concentrations of kynurenic acid and quinolinic acid are increased. The effects of both compounds were determined on the serotonergic pathway. Although kynurenic acid produced no significant effect, quinolinic acid significantly reduced N-acetylserotonin and melatonin synthesis at concentrations of lOJLM and 100 JLM respectively. Many authors have implicated oxygen derived species as causative agents in the important neurodegenerative disorders such as Parkinson's and Huntington's disease. Increased radical generation and lipid peroxidation have been suggested to be responsible for the toxic destruction of neurons, especially in the brain because of its high lipid content and oxygen demand. The brain is therefore vulnerable to oxidative attack. During inflammatory diseases, IDO is induced with a resultant increase in kynurenines. This study was also an attempt at determining the effect of kynurenines on lipid peroxidation. All metabolites of the kynurenine pathway were able to induce lipid peroxidation significantly. The antioxidative potential of various tryptophan analogues, viz. serotonin, melatonin and 6-methoxy-2-benzoxazolinone, was determined using quinolinic acid-induced lipid peroxidation. Serotonin, melatonin and 6-MBOA were able to significantly reduce quinolinic acid-induced lipid peroxidation.
2

The effect of 6-Methoxy-2-Benzoxazolinone (6-MBOA) on indoleamine regulation and its possible role in depression

Tanda, Sindiswa Eunice January 2000 (has links)
Tryptophan is an essential amino acid that is obtained from the diet. Approximately 98 % of ingested tryptophan is metabolized by the enzyme tryptophan 2,3-dioxygenase (TDO). The metabolism of tryptophan by TDO is an important determinant of tryptophan bioavailability to the brain for serotonin (5-HT) biosynthesis, an essential amine in affective disorders such as depression. Studies done on circadian rhythmicity of the enzyme activity have shown that, TDO activity is high during the scoto-phase (dark-phase), which is attributable to the de novo enzyme synthesis that occurs during this phase. 6-Methoxy-2-benzoxazolinontr-(6-MBOA), a structural analogue of melatonin (aMT) was shown to inhibit TDO activity in both the photo-phase (light-phase) and the scoto-phase with greater potency during the light-phase. Further studies were directed at demonstrating the effects of 6-MBOA on the brain tryptophan hydroxylase (TH) activity, which is a rate limiting enzyme in 5-HT biosynthesis and subsequently on 5-HT levels. The findings showed that, 6-MBOA induces TH activity with a concomitant rise in brain 5-HT levels. The blockade of 5-HT re-uptake into the presynaptic neuron leads to an increase in 5-HT available for the stimulatory action of 5-HT receptors. An attempt to establish whether the administration of 6-MBOA would block the binding of 5-HT to receptors on the synaptosomal membrane showed that 6-MBO A only inhibits the binding of 5 -HT at specific concentrations. In view of the positive effects imposed by 6-MBOA on brain 5-HT levels, urinary 5-hydroxyindole acetic acid (5-HIAA) excretion was measured before and after treatment with 6-MBOA. 5-HIAA excretion was found to be significantly increased after 6-MBOA treatment. Extensive research on the biosynthesis of pineal metabolites has been conducted in the past two decades. The pineal metabolites are synthesized from the precursor tryptophan. In order to obtain an overall picture of the effect of6-MBOA on pineal indole metabolism, an organ culture technique was employed. The results obtained showed that although 6-MBOA administration to rats caused a significant increase in aMT production, there was an insignificant increase in NAS production. This is an immediate precursor of aMT. Other pineal indoles were not affected at all by 6-MBOA administration. Furthermore, the production of pineal NAS and aMT showed an inter-individual variation with some animals producing very high, some very low and some produced average levels of these two metabolites in both photo and scoto-phase experiments. A study undertaken to investigate the circadian rhythm in endogenous aMT production using the competitive ELISA technique showed a clear pattern with high levels of aMT produced during the dark-phase and low levels ofaMT produced during the light-phase. Furthermore, the administration of6-MBOA to rats lead to a significant rise in endogenous aMT production.
3

The effect of food access schedule and diet composition on the rhythmicity of serum melatonin and pineal N-acetyltransferase activity in rats /

Oguine, Adaora. January 2002 (has links)
Melatonin is a hormone secreted by the pineal gland, which is known to modulate biological rhythms in mammals. This study investigated the effect of food access schedule and dietary composition on serum melatonin and pineal NAT activity in adult male Wistar rats. These rats were maintained on a 12:12 h light:dark schedule with lights on at 0800h. The rats were randomly assigned to two dietary groups. A group was simultaneously fed a protein-rich and carbohydrate-rich granulated diet and the other group fed granulated rat chow. Each dietary group was further divided based on dietary feeding schedules. Animals were fed between 0800--1600 h or fed ad libitum. The study revealed that protein intake of rats fed the dietary choice was lower with the restricted access than in the free access. In rats fed dietary choice, the nocturnal melatonin levels and pineal NAT activity were significantly lower under the restricted access feeding when compared to the ad libitum feeding schedule. This was not observed in rats fed single chow diet. In conclusion our data demonstrate that food composition does affect the nocturnal synthesis of melatonin as well as the activity of the enzyme NAT. This could be via dietary intake of tryptophan, which is a precursor melatonin synthesis in the pineal gland.
4

Regulation of tryptophan-2,3-dioxygenase and pineal indoleamines by selected tryptophan derivatives and antidepressants

Walsh, Harold Archibold January 1997 (has links)
The regulation of tryptophan-2,3-dioxygenase (TDO) (EC 1.13.1.12) and, to a lesser extent, pineal indoleamines, both in vitro and in vivo, is examined in this study. Rat liver TDO is a cytosolic enzyme which plays a crucial role in the regulation of circulating tryptophan (TRP) levels. Stimulation of this enzyme by heme enhances the catabolism of TRP, making less TRP available for uptake into the brain and other tissues, and for protein synthesis. At pH 7, the enzyme has an approximate Km of 100μM, is subject to substrate inhibition immediately beyond Sopt([S] at Vmax), and response of the enzyme is cooperative in both uninhibited and inhibited regions. Hill analysis of the uninhibited region reveals a biphasic plot and two classes of binding sites. Negative cooperativity is brought about through deprotonation of the enzyme. Substrate iphibition also occurs at both acidic and basic pH values with concomitant shifts in Sopt. The results obtained indicate that substrate inhibition could be an additional mechanism whereby the flux through the TRP-kynurenine pathway is regulated. TDO is subject to a diurnal rhythm, with peak activity during the pre-dark period and the loweSt activity towards the end of the dark period. It is possible that the enzyme controls the synthesis of the neurotransmitter serotonin (5-HT), and that the circadian rhythm in TDO activity is due to the endogenous rhythm of melatonin (aMT) production by the pineal gland. In the present study, aMT displaces TRP from bovine serum albumin (BSA) in vitro, and it is therefore possible for the indoleamine to regulate the availability of TRP for uptake into the brain for conversion to its derivatives. Chronic intraperitoneal administration of aMT affects physiological hepatic parameters in rats, such as TDO activity and stromal fatty acid composition, whilst no observable effect is demonstrable with respect to protein synthesis, nucleic acid metabolism, membrane fatty acid composition and pineal indole biosynthesis. On the other hand, chronic treatment of rats with antidepressants, the tricyclic desmethylimipramine (DMI) and the selective serotonin reuptake inhibitor (SSRI), fluoxetine, reveals significant negative alterations in TDO concentrations and pineal indole amine synthesis. Combining aMT with any of these two drugs normalises the activity of the hepatic enzyme. DMI is found to be an effective inhibitor of TDO in the micromolar range in vitro, and also affects total enzyme concentrations in vivo. Fluoxetine has no effect on TDO in vitro, but in vivo also reduces total enzyme levels in the liver. However, the SSRI does not affect conjugation between apo- and holoenzyme. Instead, it decreases extant holoenzyme levels. Indoleamine synthesis by the pineal gland, in organ culture, is altered by both antidepressants, although in different ways. DMI increases N-acetylserotonin levels and reduces the output of methoxyindole acetic acid and meth6xytryptophol. Fluoxetine treatment markedly reduces aMT concentrations and also brings about high levels of the 5-HT catabolites, 5-hydroxytryptophol and 5-hydroxyindole acetic acid. Insulin also lowers aMT synthesis significantly in pineal organ cultures, via a mechamsm that involves inhibition of the enzyme, N-acetyl transferase, that regulates aMT synthesis. The effects of insulin on pineal indole metabolism are due to the observation that a carbohydrate rich diet which induces insulin release elevates plasma TRP and brain 5-HT, but has no effect on pineal TRP and indole amine synthesis. It could thus be possible for insulin to have an effect on the pineal, since the latter is outside the blood brain barrier. The finilings of this study support the biogenic amine deficiency hypothesis, implicating some of the major biogenic amines such as noradrenaline (NA), 5-HT and aMT in depression. There is believed to be a deficiency of NA and 5-HT at their respective synapses in the depressed state. The drug DMI could act, firstly, by inhibiting TDO and thus increasing plasma TRP levels, and could, secondly, stimulate NA release and inhibit NA reuptake at the pineal membrane. The combined effect would be to enhance aMT synthesis, with eventual remission. Fluoxetine, on the other hand, appears to utilize a slightly different mode of action to DMI, which seems to focus on the preservation of 5-HT. The fact that aMT counteracts the effects of both antidepressants, and restores the activity of TDO to that of the controls, is also consistent with the observation that the therapeutic action of drugs such as these coincides willi the restoration of normal plasma levels of the neurohormone in depressives. In view of the biogenic amine deficiency hypothesis of depression and the contentious claim that TDO is the major peripheral determinant of brain TRP, brain 5-HT and ultimately aMT, the regulation of TDO is investigated and discussed. The study concludes that TDO activity is regulated by a number of endogenous compounds which are mainly derivatives of TRP, such as aMT and oxidized nicotinamide adenine dinucleotide and exogenous substances, of which DMI and fluoxetine are but two. In addition, modulation of IDO activity in depression appears to be an important aspect of antidepressant action. aMT, the product of the pineal gland, also has the potential to increase plasma TRP and hence forebrain TRP levels, and ultimately 5-HT concentrations, firstly by displacing TRP from serum albumin and secondly by inhibiting TDO.
5

The effect of food access schedule and diet composition on the rhythmicity of serum melatonin and pineal N-acetyltransferase activity in rats /

Oguine, Adaora. January 2002 (has links)
No description available.
6

The role of estrogen in the mood-lowering effects of acute tryptophan depletion in postmenopausal women /

Schleifer, Laura A. January 2001 (has links)
No description available.
7

The role of estrogen in the mood-lowering effects of acute tryptophan depletion in postmenopausal women /

Schleifer, Laura A. January 2001 (has links)
Depression is a major mental health problem for women. Several lines of evidence suggest that fluctuating levels of estrogen associated with various reproductive events are related to changes in mood. It has been hypothesized that estrogen may exert its influence on mood via its effect on the serotonergic system---a system frequently implicated in the regulation of mood. The major goal of the following study was to elucidate further the role of estrogen in mood regulation. To this end, we examined the role of estrogen in the mood-lowering effect of Acute Tryptohpan Deption (ATD), a technique designed to cause a marked lowering of plasma and brain tryptophan, and therefore brain serotonin levels, so that the effects of decreased serotonin on mood can be studied directly. We hypothesized that (1) exogenous estrogen may protect against the mood-lowering effects of ATD in postmenopausal women and that (2) a history of affective disturbance, particularly reproduction-related affective disturbance, would be associated with greater vulnerability to ATD as predicted by the kindling model of depression. Fifty-eight postmenopausal women were randomly assigned to treatment with estrogen (0.625 mg Premarin) or placebo in the context of prospective, double-blind, cross-over design. During the final two week sof the 12-week treatment phase, all participants completed one ATD test session and one nutritionally balanced amino acid control session. We found that: (1) treatment with exogenous estrogen significantly improved mood and menopausal symptoms as compared to placebo treatment, (2) ATD was associated with a significant lowering of mood in both groups, (3) treatment with estrogen did not protect women from ATD effects unless they responded to 11 weeks of treatment with exogenous estrogen with enhanced mood, and (4) a history of reproduction-related affective disturbance was associated with more dysphoric mood in response to ATD. In conclusion, these data provide further evi

Page generated in 0.1105 seconds